Immuno-related endocrinopathy in patients treated with immune checkpoint inhibitors

Immuno-related endocrinopathy in patients treated with immune checkpoint inhibitors

Recently immune checkpoint inhibitors amazingly changed the landscape of cancer therapy worldwide. The number of immune checkpoint molecules in clinical practice is constantly increasing. There are some monoclonal antibodies recently registered in the Russian Federation: anti-PD1 antibodies (nivolum...

Full description

Bibliographic Details
Main Authors: D. I. Yudin, K. K. Laktionov, K. A. Sarantseva, O. I. Borisova, V. V. Breder, E. V. Reutova, M. F. Beloyartseva, S. Yu. Kruteleva, I. A. Dzhanyan
Format: Article
Language:Russian
Published: Remedium Group LLC 2020-07-01
Series:Медицинский совет
Subjects:
immune-related endocrinopathy
immunotherapy
checkpoint inhibitors
anti-ctla-4
anti-pd-1/pd-l1
Online Access:https://www.med-sovet.pro/jour/article/view/5697

Internet

https://www.med-sovet.pro/jour/article/view/5697

Similar Items